Aspen Aerogels (NYSE:ASPN) Given New $28.00 Price Target at Canaccord Genuity Group

Aspen Aerogels (NYSE:ASPNFree Report) had its price target hoisted by Canaccord Genuity Group from $18.00 to $28.00 in a research report sent to investors on Friday, Benzinga reports. The firm currently has a buy rating on the construction company’s stock.

A number of other equities research analysts have also weighed in on ASPN. Roth Mkm reaffirmed a buy rating and set a $22.00 target price on shares of Aspen Aerogels in a research note on Tuesday, April 30th. B. Riley lifted their price objective on Aspen Aerogels from $24.00 to $30.00 and gave the company a buy rating in a research report on Friday. TheStreet raised Aspen Aerogels from a d+ rating to a c- rating in a research report on Wednesday, March 6th. Piper Sandler lifted their price target on Aspen Aerogels from $20.00 to $29.00 and gave the company an overweight rating in a research report on Friday. Finally, HC Wainwright upped their price target on Aspen Aerogels from $20.00 to $25.00 and gave the stock a buy rating in a research note on Friday. One investment analyst has rated the stock with a sell rating and six have given a buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of Moderate Buy and a consensus price target of $25.17.

Check Out Our Latest Report on ASPN

Aspen Aerogels Trading Up 3.1 %

ASPN opened at $25.90 on Friday. Aspen Aerogels has a one year low of $5.32 and a one year high of $25.91. The company has a debt-to-equity ratio of 0.24, a current ratio of 4.01 and a quick ratio of 3.29. The business has a 50 day simple moving average of $16.90 and a two-hundred day simple moving average of $13.90. The firm has a market capitalization of $1.97 billion, a price-to-earnings ratio of -58.86 and a beta of 1.97.

Aspen Aerogels (NYSE:ASPNGet Free Report) last announced its earnings results on Tuesday, February 13th. The construction company reported ($0.01) EPS for the quarter, beating analysts’ consensus estimates of ($0.12) by $0.11. The company had revenue of $84.22 million during the quarter, compared to the consensus estimate of $83.82 million. Aspen Aerogels had a negative return on equity of 6.35% and a negative net margin of 10.73%. During the same quarter in the prior year, the company earned ($0.20) earnings per share. Analysts predict that Aspen Aerogels will post 0.03 EPS for the current year.

Hedge Funds Weigh In On Aspen Aerogels

Hedge funds have recently bought and sold shares of the company. Banque Cantonale Vaudoise increased its stake in Aspen Aerogels by 37.5% during the 1st quarter. Banque Cantonale Vaudoise now owns 4,593 shares of the construction company’s stock valued at $81,000 after purchasing an additional 1,252 shares in the last quarter. Thompson Davis & CO. Inc. increased its position in shares of Aspen Aerogels by 14.7% during the fourth quarter. Thompson Davis & CO. Inc. now owns 24,150 shares of the construction company’s stock valued at $381,000 after acquiring an additional 3,100 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank raised its holdings in Aspen Aerogels by 38.5% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 12,971 shares of the construction company’s stock worth $205,000 after acquiring an additional 3,607 shares during the last quarter. Bouvel Investment Partners LLC lifted its position in Aspen Aerogels by 4.3% in the 4th quarter. Bouvel Investment Partners LLC now owns 94,318 shares of the construction company’s stock valued at $1,488,000 after acquiring an additional 3,929 shares in the last quarter. Finally, Mitsubishi UFJ Kokusai Asset Management Co. Ltd. boosted its stake in Aspen Aerogels by 7.1% during the 3rd quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. now owns 84,257 shares of the construction company’s stock valued at $725,000 after purchasing an additional 5,611 shares during the last quarter. Institutional investors own 97.64% of the company’s stock.

About Aspen Aerogels

(Get Free Report)

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.

Recommended Stories

Analyst Recommendations for Aspen Aerogels (NYSE:ASPN)

Receive News & Ratings for Aspen Aerogels Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels and related companies with MarketBeat.com's FREE daily email newsletter.